Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Artrip

Obstetrics & Gynecology Ronceverte, WV Medical Doctor

NPI 1407234867 CMS profile 6399513

1322 Maplewood Ave, Ronceverte, WV 24970

Open in the dashboard

General payments

$6,006

117 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Artrip of Ronceverte, WV is reported in the CMS Open Payments database as having received $6,006 across 117 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,064 9
2024 General $31 2
2023 General $380 18
2022 General $351 18
2021 General $527 31
2020 General $499 29
2019 General $155 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Artrip
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to William Artrip were reported at $4,064. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year William Artrip Obstetrics & Gynecology median Middle half National median
2019 $155 $172 $62–$391 $163
2020 $499 $94 $36–$222 $114
2021 $527 $136 $42–$369 $132
2022 $351 $160 $50–$433 $149
2023 $380 $169 $56–$423 $160
2024 $31 $152 $50–$371 $164
2025 $4,064 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $3,997 6 payments
  2. AbbVie, Inc. $378 21 payments
  3. Pfizer Inc. $298 19 payments
  4. Astellas Pharma US Inc $200 8 payments
  5. Amgen Inc. $197 13 payments
  6. Bayer HealthCare Pharmaceuticals Inc. $150 7 payments
  7. Organon LLC $146 9 payments
  8. Merck Sharp & Dohme Corporation $91 5 payments
  9. Avion Pharmaceuticals $90 5 payments
  10. CooperSurgical, Inc. $83 3 payments
  11. Other $378 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $3,122 4 payments
  2. Food and Beverage $1,905 110 payments
  3. Travel and Lodging $980 3 payments
Products named General payments · program years 2019–2025
  1. DAVINCI XI $3,000 2 payments
  2. Da Vinci Surgical System $997 4 payments
  3. PREMARIN $335 22 payments
  4. ORILISSA $279 15 payments
  5. ESTRING $275 18 payments
  6. EVENITY $197 13 payments
  7. Prolia $197 13 payments
  8. ORIAHNN $196 11 payments
  9. COLOGUARD $128 8 payments
  10. Kyleena $111 5 payments
  11. Other $1,272 72 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

90

Median for Obstetrics & Gynecology: 65

Drug cost

$3,747

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

28.9%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 52 $2,077
Estradiol (Twice Weekly) Estradiol Brand 12 $1,111
Medroxyprogesterone Acetate Generic 12 $425
Oxybutynin Chloride Er Oxybutynin Chloride Brand 14 $133

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Records

117 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record